TARDBP and amyotrophic lateral sclerosis: As the progranulin–sortilin axis has been proposed as a novel therapeutic target in ALS/FTLD, inter-species differences in regulatory mechanisms associated to the TDP-43 protein should be carefully considered when translating preclinical data obtained in mouse disease models to patients.